EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Low dose emicizumab prophylaxis in haemophilia a patients: A pilot study from India

Shweta Bansal, Anouk A M T Donners iD, Kathelijn Fischer, Shrinath Kshirsagar iD, Savita Rangarajan, Varsha Phadke, Shrutika Mhatre, Bharati Sontate, Magdelene D' Silva, Shahana Ansari, Shrimati Shetty iD

Haemophilia · 2023

DOI: 10.1111/hae.14785 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Haemophilia, 2023. Verfasst von Shweta Bansal und 10 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Center for Oncology, Haematology & Rare Disorders (ACOHRD), K. J. Somaiya Medical College & Research Center, Somaiya Ayurvihar, Mumbai, Maha…. Hauptthemen laut MEDLINE: Hemophilia A, Antibodies, Bispecific. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemophilia AAntibodies, BispecificHumansPilot ProjectsIndiaFactor VIIIAntibodies, Monoclonal, Humanized

Substanzen

Antibodies, BispecificFactor VIIIemicizumabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Advanced Center for Oncology, Haematology & Rare Disorders (ACOHRD), K. J. Somaiya Medical College & Research Center, Somaiya Ayurvihar, Mumbai, Maharashtra, India.
  • Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Center for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

ORCID-Profile: Anouk A M T Donners, Shrinath Kshirsagar, Shrimati Shetty

Zitieren

APA

Bansal, S., Donners, A. A. M. T., Fischer, K., Kshirsagar, S., Rangarajan, S., Phadke, V., Mhatre, S., Sontate, B., Silva, M., Ansari, S., & Shetty, S. (2023). Low dose emicizumab prophylaxis in haemophilia a patients: A pilot study from India. Haemophilia. https://doi.org/10.1111/hae.14785

Vancouver

Bansal S, Donners AAMT, Fischer K, Kshirsagar S, Rangarajan S, Phadke V, et al. Low dose emicizumab prophylaxis in haemophilia a patients: A pilot study from India. Haemophilia. 2023. doi:10.1111/hae.14785

BibTeX
@article{Bansal2023,
  author = {Bansal, Shweta and Donners, Anouk A M T and Fischer, Kathelijn and Kshirsagar, Shrinath and Rangarajan, Savita and Phadke, Varsha and Mhatre, Shrutika and Sontate, Bharati and Silva, Magdelene D' and Ansari, Shahana and Shetty, Shrimati},
  title = {Low dose emicizumab prophylaxis in haemophilia a patients: A pilot study from India},
  journal = {Haemophilia},
  year = {2023},
  doi = {10.1111/hae.14785}
}
Kostenlos starten →